The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections - Contacts and Locations

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

This study has been completed.

Study NCT00001035. Last updated on August 22, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001035

Locations


United States, Indiana
	Indiana Univ Hosp
	Indianapolis, Indiana, United States, 462025250

United States, New York
	Bellevue Hosp / New York Univ Med Ctr
	New York, New York, United States, 10016
	Jack Weiler Hosp / Bronx Municipal Hosp
	Bronx, New York, United States, 10465
	Bronx Municipal Hosp Ctr/Jacobi Med Ctr
	Bronx, New York, United States, 10461
	Harlem Hosp Ctr
	New York, New York, United States, 10037

United States, Pennsylvania
	Milton S Hershey Med Ctr
	Hershey, Pennsylvania, United States, 170330850
	Pennsylvania State Univ / Hershey Med Ctr
	Hershey, Pennsylvania, United States, 17033

United States, Wisconsin
	Great Lakes Hemophilia Foundation
	Wauwatosa, Wisconsin, United States, 532130127

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Schering-Plough

Investigators


Study Chair:	Gill JC

Study Chair:	Eyster ME